Genmab, Anthony Mancini
Genmab announced the creation of the role of chief operating officer and filled the position with Anthony Mancini, who joins the company from Bristol Myers Squibb.
The biotech stated that Mancini will be responsible for overseeing the company’s commercial, corporate and business development, as well as handling information technology functions.
In addition, he will join the executive management team of the Danish company to help it “achieve its inspirational vision of transforming cancer treatment.”
Mancini arrives at the company after a 23-year long career with BMS, where he left the company as head of US innovative medicines, where he led a team of more than 1,100 people working on immunology and cardiovascular diseases.